MALIGNANT ASCITES

This adverse event was reported 767 times

These drugs are most commonly taken by patients reporting MALIGNANT ASCITES:

# Drug Count
0 BEVACIZUMAB 75
1 CAPECITABINE 49
2 FLUOROURACIL 47
3 FLUOROURACIL CREAM, 0.5% 47
4 FUROSEMIDE 45
5 PEMBROLIZUMAB 45
6 PACLITAXEL 41
7 OXALIPLATIN 40
8 CARBOPLATIN 35
9 PACLITAXEL (AIBUMIN-BOUND) 35
See all common drugs associated with MALIGNANT ASCITES

MALIGNANT ASCITES is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ADALIMUMAB-AQVH 1 0.0101
1 RELACORILANT 1 0.0101
2 ERYTHROMYCIN LACTOBIONATE 1 0.0068
3 CLINDAMYCIN PHOSPHATE AND TRETINOIN 1 0.0065
4 PRILOCAINE HYDROCHLORIDE 1 0.0062
5 ZOLBETUXIMAB 8 0.0052
6 BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE 1 0.0040
7 BENZOCAINE AND MENTHOL 1 0.0038
8 DIMETICONE 1 0.0035
9 L-GLUTAMINE 1 0.0028
See all drugs enriched for association with MALIGNANT ASCITES